1. Home
  2. Analysis
  3. Fludara
  4. Transient-ischaemic-attack

Fludara and Transient ischaemic attack - a phase IV clinical study of FDA data

Summary:

Transient ischaemic attack is reported as a side effect among people who take Fludara (fludarabine phosphate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Transient ischaemic attack when taking Fludara. It is created by eHealthMe based on reports of 46,669 people who have side effects when taking Fludara from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Transient ischaemic attack?

Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)) is found to be associated with 1,586 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Transient ischaemic attack.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

46,669 people reported to have side effects when taking Fludara.
Among them, 28 people (0.06%) have Transient ischaemic attack.

Could Fludara cause Transient ischaemic attack?

Among these 28 people:

How long have people been on Fludara when they have Transient ischaemic attack? *

  • < 1 month: 88.89 %
  • 1 - 6 months: 11.11 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Transient ischaemic attack when taking Fludara? *

  • female: 35 %
  • male: 65 %

What is the age of people who have Transient ischaemic attack when taking Fludara? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 28.57 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 19.05 %
  • 50-59: 4.76 %
  • 60+: 47.62 %

What are other drugs people take besides Fludara? *

  1. Cyclophosphamide: 7 people, 25.00%
  2. Methotrexate: 7 people, 25.00%
  3. Tacrolimus: 4 people, 14.29%
  4. Acyclovir: 4 people, 14.29%
  5. Allopurinol: 4 people, 14.29%
  6. Bactrim: 4 people, 14.29%
  7. Cytarabine: 4 people, 14.29%
  8. Dexamethasone: 4 people, 14.29%
  9. Etoposide: 4 people, 14.29%
  10. Hydrocortisone Sodium Succinate: 3 people, 10.71%

What are other side effects people have besides Transient ischaemic attack? *

  1. Pleural Effusion (water on the lungs): 5 people, 17.86%
  2. Diarrhea: 5 people, 17.86%
  3. Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 5 people, 17.86%
  4. High Blood Pressure: 4 people, 14.29%
  5. Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 4 people, 14.29%
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 14.29%
  7. Fever: 4 people, 14.29%
  8. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 14.29%
  9. Septic Shock (shock due to blood infection): 4 people, 14.29%
  10. Cystitis Haemorrhagic (blood in the urine and painful voiding): 4 people, 14.29%

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 12 people, 42.86%
  2. Bone Marrow Conditioning Regimen: 5 people, 17.86%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 14.29%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 10.71%
  5. Capillary Leak Syndrome (capillary leaks plasma): 3 people, 10.71%
  6. Pneumonia: 3 people, 10.71%
  7. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 7.14%
  8. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 7.14%
  9. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 3.57%
  10. Immunodeficiency Disorders: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Transient ischaemic attack?

- Check whether Transient ischaemic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludara:

Transient ischaemic attack treatments and more:

How severe was Transient ischaemic attack and when was it recovered:

Expand to all the drugs that have ingredients of fludarabine phosphate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transient ischaemic attack:

Browse all the conditions that are associated with Transient ischaemic attack:

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.